This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A Review of Chronic Granulomatous Disease
Advances in Therapy Open Access 22 November 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Holland SM . Chronic granulomatous disease. Clin Rev Allergy Immunol 2010; 38: 3–10.
Cole T, Pearce MS, Cant AJ, Cale CM, Goldblatt D, Gennery AR . Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation. J Allergy Clin Immunol 2013; 132: 1150–1155.
van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L et al. Chronic granulomatous disease: the European experience. PLoS ONE 2009; 4: e5234.
Gungor T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet 2014; 383: 436–448.
Schuetz C, Hoenig M, Gatz S, Speth F, Benninghoff U, Schulz A et al. Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease. Immunol Res 2009; 44: 35–41.
Kikuta A, Ito M, Mochizuki K, Akaihata M, Nemoto K, Sano H et al. Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction. Bone Marrow Transplant 2006; 38: 665–669.
Tewari P, Martin PL, Mendizabal A, Parikh SH, Page KM, Driscoll TA et al. Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease. Biol Blood Marrow Transplant 2012; 18: 1368–1377.
Roos D, de Boer M, Kuribayashi F, Meischl C, Weening RS, Segal AW et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996; 87: 1663–1681.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Hoenig, M., Niehues, T., Siepermann, K. et al. Successful HLA haploidentical hematopoietic SCT in chronic granulomatous disease. Bone Marrow Transplant 49, 1337–1338 (2014). https://doi.org/10.1038/bmt.2014.125
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2014.125
This article is cited by
-
Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide in High-Risk Chronic Granulomatous Disease Patient with Invasive Mucormycosis
Journal of Clinical Immunology (2023)
-
Successful Haploidentical Transplant Using Post-Transplant Cyclophosphamide in a Child with Chronic Granulomatous Disease—First Report from the Indian Subcontinent
Journal of Clinical Immunology (2021)
-
Chronic Granulomatous Disease: a Comprehensive Review
Clinical Reviews in Allergy & Immunology (2021)
-
A Review of Chronic Granulomatous Disease
Advances in Therapy (2017)
-
Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report
Journal of Clinical Immunology (2015)